Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

THOR

Synthorx (THOR)

Synthorx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:THOR
DateTimeSourceHeadlineSymbolCompany
05/17/20079:30AMPR Newswire (US)Thoratec Presentation at Citigroup ConferenceNASDAQ:THORSynthorx Inc
05/04/20079:30AMPR Newswire (US)Thoratec Receives FDA Approval of Continued Access Protocol for Bridge ARM of Its HeartMate II(R) Pivotal TrialNASDAQ:THORSynthorx Inc
05/03/20079:30AMPR Newswire (US)Thoratec Reports 18 Percent Increase in First Quarter Revenues; HeartMate(R) II Pivotal Trial Enrollment Now at 616NASDAQ:THORSynthorx Inc
04/25/20079:30AMPR Newswire (US)Thoratec Schedules First Quarter Conference Call, WebcastNASDAQ:THORSynthorx Inc
04/23/20075:30PMPR Newswire (US)Thoratec Announces Cardiovascular Division Management TransitionNASDAQ:THORSynthorx Inc
04/02/20079:30AMPR Newswire (US)Thoratec Corporation Completes Equity-Based Compensation Review and Files 2006 10-KNASDAQ:THORSynthorx Inc
03/27/20072:00PMPR Newswire (US)HeartMate II(R) Pivotal Trial Data Demonstrate Hemodynamic Improvement, Lower Rate of Adverse Events and Improved Patient QualitNASDAQ:THOR
03/20/20079:30AMPR Newswire (US)Thoratec Corporation Receives Nasdaq Staff Determination LetterNASDAQ:THORSynthorx Inc
03/15/20079:30AMPR Newswire (US)Thoratec Presentation at Lehman Brothers Conference to Be WebcastNASDAQ:THORSynthorx Inc
03/15/20079:30AMPR Newswire (US)Thoratec Presentation at Lehman Brothers Conference to Be WebcastNASDAQ:THORSynthorx Inc
03/01/20074:15PMPR Newswire (US)Thoratec Corporation Files Form 12b-25 With Securities and Exchange CommissionNASDAQ:THORSynthorx Inc
02/28/20078:30AMPR Newswire (US)Thoratec Presentation at Raymond James Conference to Be WebcastNASDAQ:THORSynthorx Inc
02/15/20078:30AMPR Newswire (US)Thoratec Reports Fiscal 2006 Results; Enrollment in HeartMate II(R) Trial More Than Doubles in Past Year, Surpassing 500 PatientNASDAQ:THORSynthorx Inc
02/12/20078:30AMPR Newswire (US)HeartMate(R) II Pivotal Trial Data to Be Featured in Late-Breaking Presentation at 2007 ACC Scientific SessionNASDAQ:THORSynthorx Inc
02/05/20071:14PMPR Newswire (US)Thoratec Schedules 2006 Year-End Conference Call, WebcastNASDAQ:THORSynthorx Inc
01/03/20078:30AMPR Newswire (US)Thoratec Presentation at JP Morgan Conference to be WebcastNASDAQ:THORSynthorx Inc
12/21/20066:59PMPR Newswire (US)Thoratec Completes Filing of PMA Seeking Bridge-to-Transplantation Approval for HeartMate(R) IINASDAQ:THORSynthorx Inc
12/04/20068:30AMPR Newswire (US)Thoratec Corporation Names David Smith Chief Financial OfficerNASDAQ:THORSynthorx Inc
11/21/20068:30AMPR Newswire (US)Thoratec Presentation at Lazard Capital Markets Conference to Be WebcastNASDAQ:THORSynthorx Inc
10/31/20068:30AMPR Newswire (US)Thoratec Reports Third Quarter 2006 Results; Announces Filing of First Two Modules of PMA Seeking Bridge-to-Transplantation ApprNASDAQ:THORSynthorx Inc
10/25/20062:00PMPR Newswire (US)Thoratec Schedules Third Quarter Conference Call, WebcastNASDAQ:THORSynthorx Inc
10/03/20065:05PMPR Newswire (US)Thoratec's ITC Division Acquires A-VOX SystemsNASDAQ:THORSynthorx Inc
09/07/20069:30AMPR Newswire (US)Thoratec Presentation at Bear Stearns Conference to Be WebcastNASDAQ:THORSynthorx Inc
08/30/20065:30PMPR Newswire (US)Thoratec Announces Chief Financial Officer Transition Will Occur at End of 2006NASDAQ:THORSynthorx Inc
08/24/20069:30AMPR Newswire (US)Thoratec and Levitronix Announce U.S. Co-Distribution Agreement for Levitronix(R) CentriMag(R) SystemNASDAQ:THORSynthorx Inc
08/02/20069:30AMPR Newswire (US)Thoratec Presentation at Canaccord Adams Conference to Be WebcastNASDAQ:THORSynthorx Inc
07/31/20069:30AMPR Newswire (US)Thoratec Reports 15 Percent Growth in Quarterly Revenues Driven by 28 Percent Growth in VAD SalesNASDAQ:THORSynthorx Inc
07/24/20069:30AMPR Newswire (US)Thoratec Schedules Second Quarter Conference Call, WebcastNASDAQ:THORSynthorx Inc
05/31/20069:30AMPR Newswire (US)Thoratec Announces Completion of Enrollment in Bridge-to-Transplantation Arm of HeartMate(R) II Pivotal TrialNASDAQ:THORSynthorx Inc
05/16/20069:30AMPR Newswire (US)Thoratec Receives FDA Approval of Continued Access Protocol for Bridge Arm of Its HeartMate(R) II Pivotal TrialNASDAQ:THORSynthorx Inc
 Showing the most relevant articles for your search:NASDAQ:THOR